Is There a Right to Psychedelic-Assisted Therapy?
Zak A. Kopeikin
The American Journal of Bioethics January 13, 2025 DOI: 10.1080/15265161.2024.2433417 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Intervention | Psychedelic-assisted therapy |
| Topics | Psychedelic-assisted therapy |
| Keywords | Fundamental rights Mental health Healthcare access |
| Key findings | Psychedelic-assisted therapy is being researched as a potential treatment for clinical psychiatric conditions such as treatment-resistant depression, anxiety, and PTSD. |
Abstract
Current research on psychedelic-assisted therapy (PAT) focuses on their potential to treat clinical psychiatric conditions such as treatment-resistant depression, anxiety, and PTSD. Presumably, if ...
Comparable studies
Other narrative reviews on psychedelic-assisted therapy, most cited first.
Citations in the library
Cites 3
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Journal of Psychopharmacology November 30, 2016
- Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects. Psychopharmacology December 1, 2011
- Belief Now, True Belief Later: The Epistemic Advantage of Self-Related Insights in Psychedelic-Assisted Therapy Philosophy and the Mind Sciences January 25, 2022